Daejeon, South Korea

Nahm Ryune Cho

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Nahm Ryune Cho: Innovator in Pharmaceutical Chemistry

Introduction

Nahm Ryune Cho is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of eight patents. His work focuses on developing compounds that can positively impact health and treat various disorders.

Latest Patents

Among his latest patents are the imidazopyrimidine and imidazotriazine derivatives, which include a pharmaceutical composition comprising these compounds. The disclosed compounds act as positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5). This innovation is particularly useful in the prevention or treatment of disorders mediated by glutamate dysfunction and mGluR5.

Career Highlights

Nahm Ryune Cho has worked with notable companies in the pharmaceutical industry, including SK Biopharmaceuticals Co., Ltd. and Amicogen, Inc. His expertise in drug development and chemistry has positioned him as a key figure in advancing therapeutic solutions.

Collaborations

Some of his notable coworkers include Ju Young Lee and Chun Eung Park, who have collaborated with him on various projects in the pharmaceutical sector.

Conclusion

Nahm Ryune Cho's innovative work in pharmaceutical chemistry and his numerous patents highlight his significant contributions to the field. His research continues to pave the way for advancements in treatments for disorders related to glutamate dysfunction.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…